Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Palisade Bio Inc (PALI)

Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108 GlobeNewswire - Wed Apr 9, 7:30AM CDT

PALI : 0.7600 (+0.58%)
Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/b Study of PALI-2108 GlobeNewswire - Fri Mar 14, 7:30AM CDT

PALI : 0.7600 (+0.58%)
Palisade Bio Announces Two Abstracts Selected to be Showcased as Poster of Distinction and Poster Presentation at Leading GI Forum, Digestive Disease Week (DDW) 2025 GlobeNewswire - Wed Mar 12, 7:30AM CDT

PALI : 0.7600 (+0.58%)
Palisade Bio Participates in Virtual Investor “What This Means” Segment GlobeNewswire - Tue Mar 4, 7:30AM CST

PALI : 0.7600 (+0.58%)
Palisade Bio, Inc. Announces Receipt of Cash Proceeds from Canada’s SR&ED Tax Incentive Program for Reimbursement of Development Costs of PALI-2108 for Treatment of Ulcerative Colitis (UC)  GlobeNewswire - Thu Feb 20, 7:45AM CST

PALI : 0.7600 (+0.58%)
Palisade Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference GlobeNewswire - Wed Feb 19, 8:00AM CST

PALI : 0.7600 (+0.58%)
Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand ACCESS Newswire - Wed Feb 19, 2:55AM CST

- Access video webcasts from the first wave of participating companies here

AKTX : 1.4100 (+2.92%)
AREC : 0.9681 (-4.15%)
OTLK : 1.5650 (+0.32%)
AMIX : 2.23 (-11.86%)
CNSP : 1.0200 (-0.97%)
PALI : 0.7600 (+0.58%)
NVNO : 2.93 (-1.52%)
HURA : 3.65 (-6.89%)
GRI : 1.8700 (+3.89%)
Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis GlobeNewswire - Mon Feb 10, 7:45AM CST

PALI : 0.7600 (+0.58%)
Palisade Bio Selected for Poster Presentation at the 2025 Crohn’s & Colitis Congress GlobeNewswire - Wed Jan 29, 7:45AM CST

PALI : 0.7600 (+0.58%)
Palisade Bio to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar GlobeNewswire - Wed Jan 22, 7:00AM CST

PALI : 0.7600 (+0.58%)

Barchart Exclusives

Elon Musk Could Bring Nvidia Stock $20 Billion Worth of Good News Barchart - 22 minutes ago
Much of the reported fundraising is expected to be spent on buying Nvidia hardware. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot